These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 3484628

  • 1. Persistent depletion of striatal dopamine in mice by 1-methyl-4-(2-thienyl)-1,2,3,6-tetrahydropyridine (MTTP).
    Fuller RW, Robertson DW, Hemrick-Luecke SK.
    Biochem Pharmacol; 1986 Jan 15; 35(2):143-4. PubMed ID: 3484628
    [No Abstract] [Full Text] [Related]

  • 2. Comparison of the effects of two 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs, 1-methyl-4-(2-thienyl)-1,2,3,6-tetrahydropyridine and 1-methyl-4-(3-thienyl)-1,2,3,6-tetrahydropyridine, on monoamine oxidase in vitro and on dopamine in mouse brain.
    Fuller RW, Robertson DW, Hemrick-Luecke SK.
    J Pharmacol Exp Ther; 1987 Feb 15; 240(2):415-20. PubMed ID: 3100775
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Persistent depletion of striatal dopamine and its metabolites in mice by TMMP, an analogue of MPTP.
    Fuller RW, Hemrick-Luecke SK.
    J Pharm Pharmacol; 1987 Aug 15; 39(8):667-9. PubMed ID: 2888865
    [Abstract] [Full Text] [Related]

  • 5. Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on levels of glutathione in the extrapyramidal system of the mouse.
    Ferraro TN, Golden GT, DeMattei M, Hare TA, Fariello RG.
    Neuropharmacology; 1986 Sep 15; 25(9):1071-4. PubMed ID: 2430229
    [Abstract] [Full Text] [Related]

  • 6. Characterization of the neurotoxic potential of m-methoxy-MPTP and the use of its N-ethyl analogue as a means of avoiding exposure to a possible Parkinsonism-causing agent.
    Zimmerman DM, Cantrell BE, Reel JK, Hemrick-Luecke SK, Fuller RW.
    J Med Chem; 1986 Aug 15; 29(8):1517-20. PubMed ID: 3488406
    [Abstract] [Full Text] [Related]

  • 7. Synthesis and toxicity toward nigrostriatal dopamine neurons of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) analogues.
    Fries DS, de Vries J, Hazelhoff B, Horn AS.
    J Med Chem; 1986 Mar 15; 29(3):424-7. PubMed ID: 3485197
    [Abstract] [Full Text] [Related]

  • 8. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration to C57-black mice leads to parallel decrements in neostriatal dopamine content and tyrosine hydroxylase activity.
    Mayer RA, Walters AS, Heikkila RE.
    Eur J Pharmacol; 1986 Jan 29; 120(3):375-7. PubMed ID: 2868908
    [Abstract] [Full Text] [Related]

  • 9. Influence of selective, reversible inhibitors of monoamine oxidase on the prolonged depletion of striatal dopamine by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
    Fuller RW, Hemrick-Luecke SK.
    Life Sci; 1985 Sep 23; 37(12):1089-96. PubMed ID: 3875779
    [Abstract] [Full Text] [Related]

  • 10. A high dose of MPTP overcomes the protective effect of selegiline against dopaminergic neurotoxicity.
    Fuller RW, Hemrick-Luecke SK.
    J Pharm Pharmacol; 1989 Jul 23; 41(7):492-3. PubMed ID: 2570859
    [Abstract] [Full Text] [Related]

  • 11. Studies on the mechanism of the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Heikkila RE, Nicklas WJ, Duvoisin RC.
    Adv Neurol; 1987 Jul 23; 45():149-52. PubMed ID: 3103384
    [No Abstract] [Full Text] [Related]

  • 12. Evaluation of the biological activity of several analogs of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Youngster SK, Sonsalla PK, Heikkila RE.
    J Neurochem; 1987 Mar 23; 48(3):929-34. PubMed ID: 3492590
    [Abstract] [Full Text] [Related]

  • 13. Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal tyrosine hydroxylase and tryptophan hydroxylase in rat.
    Matsuda LA, Schmidt CJ, Hanson GR, Gibb JW.
    Neuropharmacology; 1986 Mar 23; 25(3):249-55. PubMed ID: 2871513
    [Abstract] [Full Text] [Related]

  • 14. Increase of striatal dopamine turnover by stress in MPTP-treated mice.
    Urakami K, Masaki N, Shimoda K, Nishikawa S, Takahashi K.
    Clin Neuropharmacol; 1988 Aug 23; 11(4):360-8. PubMed ID: 3264755
    [Abstract] [Full Text] [Related]

  • 15. Effects of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine on neostriatal dopamine in mice.
    Heikkila RE, Cabbat FS, Manzino L, Duvoisin RC.
    Neuropharmacology; 1984 Jun 23; 23(6):711-3. PubMed ID: 6611514
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Effect of acidic fibroblast growth factor on experimental parkinsonism and levels of dopamine and its metabolites in the striatum of mice of various ages].
    Kucherianu VG, Kryzhanovskiĭ GN, Kudrin VS, Iurasov VV, Nikushkin EV, Zhigal'tsev IV.
    Biull Eksp Biol Med; 1999 May 23; 127(5):502-5. PubMed ID: 10399565
    [No Abstract] [Full Text] [Related]

  • 19. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions.
    Sirinathsinghji DJ, Heavens RP, McBride CS.
    Brain Res; 1988 Mar 08; 443(1-2):101-16. PubMed ID: 3258784
    [Abstract] [Full Text] [Related]

  • 20. Assessment of the role of multidrug resistance-associated proteins in MPTP neurotoxicity in mice.
    Plangár I, Zádori D, Szalárdy L, Vécsei L, Klivényi P.
    Ideggyogy Sz; 2013 Nov 30; 66(11-12):407-14. PubMed ID: 24555241
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.